Clinical Trial Update: Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating retreatment of chronic hepatitis C in dialysis patients using pegylated interferon alfa-2a plus low-dose ribavirin; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C, Hemodialysis | Phase 4 | Status: COMPLETED | Results posted: 2009-11-13